Skip to main content
TipRanks
Go Ultimate75% OFF

Sangamo Therapeutics (GBY) Q2 2018 Earnings Report

4 Followers

DE:GBY Q2 2018 EPS Results

Actual EPS
-EUR 0.15
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 0.15

DE:GBY Q2 2018 Revenue Results

Actual Revenue
EUR 19.05M
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
―

Earnings Announcement Details

Quarter
Q2 2018
Date
08/08/2018
Time
After Close
Conference Call
Wednesday, August 8, 2018
DE:GBY Upcoming Earnings

Sangamo Therapeutics's next earnings date is estimated for February 24, 2027, based on past reporting schedules.

Q2 2018 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2018 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2018 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:GBY Earnings History

DE:GBY earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Feb 24, 20272026 (Q4)―--0.1――
Oct 29, 20262026 (Q3)―--0.1―
Aug 11, 20262026 (Q2)-0.06--0.07―
May 14, 20262026 (Q1)0.00-0.07-0.1242.86% (+0.05)
Mar 30, 20262025 (Q4)0.01-0.10-0.10.00% (+0.00)
Nov 06, 20252025 (Q3)0.00-0.100.04-375.00% (-0.13)
Aug 07, 20252025 (Q2)-0.01-0.07-0.1655.56% (+0.09)
May 12, 20252025 (Q1)-0.10-0.12-0.2448.15% (+0.12)
Mar 17, 20252024 (Q4)-0.08-0.10-0.367.65% (+0.20)
Nov 12, 20242024 (Q3)-0.010.04-0.52106.78% (+0.56)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed